Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Eureka Genomics Lands a NIFA Award for $100,000

Published: Thursday, June 28, 2012
Last Updated: Thursday, June 28, 2012
Bookmark and Share
Development of bovine parentage genotyping by highly multiplex next generation sequencing.

The National Institute of Food and Agriculture (NIFA), USDA issued a $100,000 award for the development of Bovine Parentage Genotyping by Highly Multiplex Next Generation Sequencing.

This project is related to a Cooperative Research and Development Agreement (CRADA) between Eureka Genomics and the Agricultural Research Service, USDA to develop a low cost, low-density marker assay (LDMA) focused on the bovine industry.

The core technology for low cost high-throughput genotyping will have applications across animal, plant and clinical markets.

"The collaboration has resulted in a very cost-effective, high-throughput approach to single nucleotide polymorphism (SNP) genotyping, which is currently available for bovine parentage testing as well as for custom applications. Continuing development efforts are focused on increasing the number of SNPs that can be included in an assay, on further reducing the costs of adding SNP to assays, and on expanding the approach to include additional types of polymorphisms," said Mark Thallman, Ph.D. Research Geneticist and co-inventor of the technology, at the U.S. Meat Animal Research Center.

"The success of and knowledge created during the collaboration between Eureka Genomics and the USDA on LDMA for high-throughput genotyping is being leveraged into an ongoing collaboration between Eureka Genomics and the USDA that has expanded to include many diverse areas including 16S characterization and improved sample handling for next generation sequencing. Eureka Genomics is very pleased to continue to work with the U.S. Meat Animal Research Center to improve the applications of high throughput sequence data in the agricultural setting," said Heather Koshinsky, PhD., CSO, Eureka Genomics.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Breast Cancer Drug Hope
A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.
Harnessing Nature’s Vast Array of Venoms for Drug Discovery
Scripps scientists have developed a method for rapidly identifying venoms.
A New Platform for Discovering Antibiotics
Harvard chemists hope to shorten time, difficulty in measuring their effectiveness, potential.
The Need for Speed
Evaluating MALDI-TOF as a high-throughput screening technology for the pharmaceutical industry.
Antarctic Sponge Extract Kills MRSA
New findings may provide opportunity for developing new drugs to fight dangerous bacteria currently highly resistant to treatment.
US-India Collab Finds Molecular Signatures of Severe Malaria
Study may be a significant advancement in understanding the causes of severe malaria.
Novel Way to Prevent Deadly Bacterial Infections
Monash scientists may have found a way to stop deadly bacteria from infecting patients. The discovery could lead to a whole new way of treating antibiotic-resistant “superbugs”
Gene Expression Controls Revealed
Researchers have modelled every atom in a key part of the process for switching on genes, revealing a whole new area for potential drug targets.
An Old-New Weapon Against Emerging Chikungunya Virus
Researchers utilize existing drugs to interfere with host factors required for replication of Chikungunya virus.
Using Gene-editing Technology for Faster, Cheaper Antiviral Drug Development
UCLA scientists are working to develop special screening libraries based on a gene-editing technology called CRISPR.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!